Ensign Peak Advisors, Inc Hutchmed (China) LTD Transaction History

Ensign Peak Advisors, Inc

  • $54.2 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
BUY
$35.66 - $42.94 $28,527 - $34,352
800 Added 14.55%
6,300 $231,000
Q2 2021

Aug 13, 2021
BUY
$23.7 - $39.27 $7,110 - $11,781
300 Added 5.77%
5,500 $216,000
Q1 2021

May 12, 2021
BUY
$27.01 - $36.8 $105,339 - $143,520
3,900 Added 300.0%
5,200 $147,000
Q4 2020

Feb 12, 2021
BUY
$27.51 - $34.36 $35,763 - $44,668
1,300 New
1,300 $42,000

Others Institutions Holding HCM

# of Institutions
66
Shares Held
8.25M
Call Options Held
3.8K
Put Options Held
2.4K
View Full List

About HUTCHMED (China) Ltd

HCM Quotes by TradingView
  • Ticker HCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 172,955,008
  • Market Cap $3.11B
  • Description
  • HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...
More about HCM
Track This Portfolio

Track Ensign Peak Advisors, Inc Portfolio

Follow Ensign Peak Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email